Vivos Inc. (OTCMKTS:RDGL) Sees Significant Decrease in Short Interest

Vivos Inc. (OTCMKTS:RDGL) was the recipient of a significant decline in short interest in December. As of December 15th, there was short interest totalling 64,900 shares, a decline of 27.5% from the November 30th total of 89,500 shares. Based on an average daily volume of 2,331,100 shares, the short-interest ratio is presently 0.0 days.

Vivos Stock Down 3.8 %

RDGL traded down $0.00 during trading on Friday, hitting $0.12. 678,729 shares of the company’s stock were exchanged, compared to its average volume of 1,269,331. The stock has a market cap of $50.68 million, a P/E ratio of -11.54 and a beta of 0.94. The business’s 50 day moving average is $0.11 and its two-hundred day moving average is $0.14. Vivos has a fifty-two week low of $0.05 and a fifty-two week high of $0.26.

About Vivos

Vivos Inc, a radiation oncology medical device company, develops brachytherapy devices for the treatment of non-resectable tumors in the United States. It develops yttrium-90 based RadioGel device, an injectable particle-gel for brachytherapy radiation treatment of cancerous tumors in people and animals; and IsoPet for the treatment of solid tumors in animals.